JPH04222594A - Production of glucotetrasaccharide - Google Patents
Production of glucotetrasaccharideInfo
- Publication number
- JPH04222594A JPH04222594A JP2406104A JP40610490A JPH04222594A JP H04222594 A JPH04222594 A JP H04222594A JP 2406104 A JP2406104 A JP 2406104A JP 40610490 A JP40610490 A JP 40610490A JP H04222594 A JPH04222594 A JP H04222594A
- Authority
- JP
- Japan
- Prior art keywords
- dextranase
- glucotetrasaccharide
- subjected
- dextran
- arthrobacter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 5
- 108010001682 Dextranase Proteins 0.000 claims abstract description 25
- 229920002307 Dextran Polymers 0.000 claims abstract description 11
- 235000000346 sugar Nutrition 0.000 claims description 9
- 241000186074 Arthrobacter globiformis Species 0.000 claims description 7
- FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 abstract description 15
- 229910001424 calcium ion Inorganic materials 0.000 abstract description 6
- 239000000243 solution Substances 0.000 abstract description 5
- 239000007864 aqueous solution Substances 0.000 abstract description 4
- 238000004440 column chromatography Methods 0.000 abstract description 4
- 238000002523 gelfiltration Methods 0.000 abstract description 4
- 238000005185 salting out Methods 0.000 abstract description 4
- 241000186063 Arthrobacter Species 0.000 abstract description 3
- 239000007853 buffer solution Substances 0.000 abstract description 3
- 239000003906 humectant Substances 0.000 abstract description 3
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 abstract description 2
- 239000007788 liquid Substances 0.000 abstract description 2
- 239000002244 precipitate Substances 0.000 abstract description 2
- 239000006228 supernatant Substances 0.000 abstract description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 abstract 4
- 229910052921 ammonium sulfate Inorganic materials 0.000 abstract 1
- 235000011130 ammonium sulphate Nutrition 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000001816 cooling Methods 0.000 abstract 1
- 238000005342 ion exchange Methods 0.000 abstract 1
- 238000009630 liquid culture Methods 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 6
- DFKPJBWUFOESDV-NGZVDTABSA-N (2S,3R,4S,5S,6R)-6-[[(2S,3R,4S,5S,6R)-3,4,5-Trihydroxy-6-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxymethyl]oxan-2-yl]oxymethyl]oxane-2,3,4,5-tetrol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H]2[C@H]([C@H](O)[C@@H](O)[C@@H](OC[C@@H]3[C@H]([C@H](O)[C@@H](O)[C@@H](O)O3)O)O2)O)O1 DFKPJBWUFOESDV-NGZVDTABSA-N 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 239000008351 acetate buffer Substances 0.000 description 5
- 239000000872 buffer Substances 0.000 description 5
- DBTMGCOVALSLOR-AXAHEAMVSA-N galactotriose Natural products OC[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](CO)O[C@@H](O[C@H]3[C@@H](O)[C@H](O)O[C@@H](CO)[C@@H]3O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O DBTMGCOVALSLOR-AXAHEAMVSA-N 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 238000006911 enzymatic reaction Methods 0.000 description 4
- 108010055265 exo-1,6-alpha-glucosidase Proteins 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 3
- 102100022624 Glucoamylase Human genes 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 229910001961 silver nitrate Inorganic materials 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- FZWBNHMXJMCXLU-UHFFFAOYSA-N 2,3,4,5-tetrahydroxy-6-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyhexanal Chemical compound OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OCC(O)C(O)C(O)C(O)C=O)O1 FZWBNHMXJMCXLU-UHFFFAOYSA-N 0.000 description 2
- 241000235545 Rhizopus niveus Species 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 229940119743 dextran 70 Drugs 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 108010000320 glucan 1,6-alpha-isomaltosidase Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000012521 purified sample Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- QSESWLKFTMBIPZ-UHFFFAOYSA-N 4'-O-glucosyl-beta-gentiobiose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OCC2C(C(O)C(O)C(O)O2)O)C(O)C1O QSESWLKFTMBIPZ-UHFFFAOYSA-N 0.000 description 1
- ZCLAHGAZPPEVDX-UHFFFAOYSA-N D-panose Natural products OC1C(O)C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC1COC1C(O)C(O)C(O)C(CO)O1 ZCLAHGAZPPEVDX-UHFFFAOYSA-N 0.000 description 1
- 229920002271 DEAE-Sepharose Polymers 0.000 description 1
- GUBGYTABKSRVRQ-WFVLMXAXSA-N DEAE-cellulose Chemical compound OC1C(O)C(O)C(CO)O[C@H]1O[C@@H]1C(CO)OC(O)C(O)C1O GUBGYTABKSRVRQ-WFVLMXAXSA-N 0.000 description 1
- AYRXSINWFIIFAE-SCLMCMATSA-N Isomaltose Natural products OC[C@H]1O[C@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)[C@@H](O)[C@@H](O)[C@@H]1O AYRXSINWFIIFAE-SCLMCMATSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- PIBXBCFBUUZPRF-UHFFFAOYSA-N isocyclomaltohexaose Natural products OCC1OC2OCC3OC(OC4C(O)C(O)C(OC4CO)OC5C(O)C(O)C(OC5CO)OC6C(O)C(O)C(OC6CO)OC7C(O)C(O)C(OC7CO)OC1C(O)C2O)C(O)C(O)C3O PIBXBCFBUUZPRF-UHFFFAOYSA-N 0.000 description 1
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 description 1
- FOMCONPAMXXLBX-MQHGYYCBSA-N isopanose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H](O)[C@H]([C@H](O)[C@@H](O)C=O)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 FOMCONPAMXXLBX-MQHGYYCBSA-N 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- ZCLAHGAZPPEVDX-MQHGYYCBSA-N panose Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@@H](O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)C=O)O[C@@H]1CO[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 ZCLAHGAZPPEVDX-MQHGYYCBSA-N 0.000 description 1
- 238000004816 paper chromatography Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Landscapes
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
【0001】0001
【産業上の利用分野】本発明は、グルコ4糖である3−
O−α−D−グルコシル−D−イソマルトトリオースの
酵素的製造法に関する。[Industrial Application Field] The present invention relates to the glucotetrasaccharide 3-
The present invention relates to a method for enzymatically producing O-α-D-glucosyl-D-isomaltotriose.
【0002】0002
【従来の技術】グルコ4糖、即ち3−O−α−D−グル
コシル−D−イソマルトトリオース(3−O−α−D
−glucosyl−D −isomaltotrio
se) はデキストランのアースロバクター・グロビホ
ルミス(Arthrobacter globifor
mis) T6 由来のイソマルトデキストラナーゼの
酵素分解物として知られている(Biochemica
l and Biophysical Researc
hi Communicatios Vol.70 N
o.2, 459−464(1976))。しかし、デ
キストラナーゼI又はデキストラナーゼIIによる酵素
的生造法は知られていない。[Prior Art] Glucotetrasaccharide, 3-O-α-D-glucosyl-D-isomaltotriose (3-O-α-D
-glucosyl-D -isomaltotrio
se) is the dextran Arthrobacter globiformis (Arthrobacter globiformis).
Mis) It is known as an enzymatic decomposition product of isomaltodextranase derived from T6 (Biochemica
l and Biophysical Research
hi Communicatios Vol. 70N
o. 2, 459-464 (1976)). However, no enzymatic production method using dextranase I or dextranase II is known.
【0003】0003
【発明が解決しようとする課題】本発明は、式(I)で
示したグルコ4糖の酵素的製造法を提供することを目的
とする。SUMMARY OF THE INVENTION An object of the present invention is to provide a method for enzymatically producing glucotetrasaccharide represented by formula (I).
【0004】0004
【課題を解決するための手段】本発明のグルコ4糖は、
式(I):[Means for solving the problems] The glucotetrasaccharide of the present invention is
Formula (I):
【0005】[0005]
【0006】で示されるものであり、3−O−α−D
−グルコシル−D −イソマルトトリオース(3−O−
α−D −glucosyl−D −isomalto
triose) 又はO−α−D −グルコピラノシル
−(1→3)−O−α−D −グルコピラノシル−(1
→6)−O−α−D −グルコピラノシル−(1→6)
−D −グルコース、(O−α−D −Glcp−(1
→3)−O−α−D −Glcp−(1→6)−O−α
−D −Glcp−(1→6)−D−Glc )と命名
されるものである。3-O-α-D
-Glucosyl-D-isomaltotriose (3-O-
α-D-glucosyl-D-isomalto
triose) or O-α-D-glucopyranosyl-(1→3)-O-α-D-glucopyranosyl-(1
→6)-O-α-D-glucopyranosyl-(1→6)
-D-glucose, (O-α-D-Glcp-(1
→3)-O-α-D -Glcp-(1→6)-O-α
-D-Glcp-(1→6)-D-Glc).
【0007】本発明のグルコ4糖の製造法は、デキスト
ランT2000(ファルマシア製)等のデキストランを
アースロバクター・グロビフォルミス(Arthrob
acter globiformis)W31 株(N
RRL B−4428) 起源のデキストラナーゼI又
はデキストラナーゼIIで酵素反応させることからなる
。本発明で使用する基質としてのデキストランとしては
、ファルマシア製のデキストランT2000や名糖産業
製の名糖70等が使用できる。[0007] The method for producing glucotetrasaccharides of the present invention involves injecting dextran such as Dextran T2000 (manufactured by Pharmacia) into Arthrobacter globiformis (Arthrobacter globiformis).
Acter globiformis) W31 strain (N
RRL B-4428) consists of an enzymatic reaction using the original dextranase I or dextranase II. As the dextran used as a substrate in the present invention, Dextran T2000 manufactured by Pharmacia, Meito 70 manufactured by Meito Sangyo, etc. can be used.
【0008】前記デキストラナーゼI及びデキストラナ
ーゼIIは、それぞれ特開平1−228466号公報及
び特開平1−228467号公報に、その製造法ととも
に開示されている。前記酵素反応は、デキストラナーゼ
I及びIIの両酵素とも、反応温度30〜55℃、pH
5〜7、デキストランT2000濃度2〜8%で行うこ
とが好ましい。但し、反応時間は、デキストラナーゼI
では0.5 〜2時間以上、デキストラナーゼIIでは
1〜3時間以上が好ましい。[0008] Dextranase I and Dextranase II are disclosed in JP-A-1-228466 and JP-A-1-228467, respectively, together with their production methods. In the enzymatic reaction, both dextranase I and II enzymes were used at a reaction temperature of 30 to 55°C and a pH of
5 to 7, and dextran T2000 concentration is preferably 2 to 8%. However, the reaction time is dextranase I
For Dextranase II, the time is preferably 0.5 to 2 hours or more, and for Dextranase II, it is preferably 1 to 3 hours or more.
【0009】以上のようにして得られる反応生成物は、
グルコ4糖(I)の他、イソマルトトリオース、イソマ
ルトテトラオース等を含むものであり、通常の分離・精
製手段、例えばカラムクロマトグラフィーにより、ある
程度精製することができるが、好ましくは、アースロバ
クター・グロビフォルミス(Arthrobacter
globiformis)I42株(NRRL B−
4427,IAM 12102)起源のグルコデキスト
ラナーゼによって副生成物であるイソマルトトリオース
、イソマルトテトラオース等をグルコースにまで加水分
解することによって除去する。The reaction product obtained in the above manner is
In addition to glucotetrasaccharide (I), it contains isomaltotriose, isomaltotetraose, etc., and can be purified to some extent by ordinary separation and purification means, such as column chromatography, but preferably earth Lobacter globiformis (Arthrobacter)
globiformis) I42 strain (NRRL B-
4427, IAM 12102) By-products such as isomaltotriose and isomaltotetraose are hydrolyzed to glucose using the original glucodextranase and removed.
【0010】以上のようにして得られるグルコ4糖(I
)は、保湿性が高いことから、食品工業における保湿剤
として有用である。
調製例 デキストララナーゼI及びIIの調製(1)
アースロバクター・グロビフォルミス(Arthr
obacter globifomis)W31株(N
RRL B−4428) を30℃で3日間ジャーファ
メンターを用いて液体培養し、その培養液3Lを高速冷
却連続遠心(10,000 ×g)にかけ、菌体除去後
に得られた上清液を90%飽和の硫酸アンモニウム水溶
液で塩析した。次いで、塩析沈澱物を5mMのCa2+
を含有する20 mM 酢酸緩衝液(pH 6.0)
に溶解し、同上緩衝液に対して透析したものを同上緩衝
液で充分平衡化したDEAE−セルロースを充填したカ
ラム(4.4 × 70 cm) にのせた。このカ
ラムクロマトグラフィーにおいて0.2 M のNaC
lを含有する同上緩衝液で溶出される活性画分を集めた
。
(2) 得られた活性画分を濃縮後、同上緩衝液で充
分平衡化したBio−Gel P−150 を充填した
カラム(1.8 × 120 cm)にかけ、ゲル濾
過を行った。[0010] Glucotetrasaccharide (I
) is useful as a humectant in the food industry due to its high moisturizing properties. Preparation example Preparation of dextralanase I and II (1)
Arthrobacter globiformis (Arthr)
obacter globifomis) W31 strain (N
RRL B-4428) was cultured in liquid at 30°C for 3 days using a jar fermenter, 3L of the culture solution was subjected to high-speed refrigerated continuous centrifugation (10,000 × g), and the supernatant obtained after removing the bacterial cells was Salting out was carried out with a 90% saturated ammonium sulfate aqueous solution. The salting out precipitate was then treated with 5mM Ca2+
20 mM acetate buffer (pH 6.0) containing
The solution was dissolved in the same buffer and dialyzed against the same buffer, and then applied to a column (4.4 x 70 cm) packed with DEAE-cellulose that had been sufficiently equilibrated with the same buffer. In this column chromatography, 0.2 M NaC
The active fraction eluted with the same buffer containing 1. (2) After concentrating the obtained active fraction, it was applied to a column (1.8 x 120 cm) packed with Bio-Gel P-150 sufficiently equilibrated with the same buffer solution and subjected to gel filtration.
【0011】このゲル濾過で2個の活性画分が得られる
が、そのうち先に溶出された画分を集め、濃縮後、同上
緩衝液で充分平衡化したDEAE−セファロースを充填
したカラム(1.2 × 50 cm) にのせ、0
M から0.3 M までのNaCl水溶液による直
線濃度勾配をかけて酵素を溶出した。0.14 M付近
のNaCl水溶液で溶出される単一の活性画分を集め、
濃縮・透析してデキストラナーゼIの精製標品(力価:
30.6ユニット/mg ・蛋白質) を得た。
(3) 一方、前述のゲル濾過で得られた2個の活性
画分のうち、後から溶出される画分を集め、濃縮後、同
上緩衝液で充分平衡化したDEAE−セファロースを充
填したカラム(1.2 × 50 cm) にのせ、
0M から0.3 M までのNaCl水溶液による直
線濃度勾配をかけて酵素を溶出した。0.16 M付近
のNaCl水溶液で溶出される単一の活性画分を集め、
濃縮・透析してデキストラナーゼIIの精製標品 (力
価:59.2 ユニット/mg 蛋白質) を得た。
(4) 以上のようにして得られたデキストラナーゼ
I及びIIの理化学的及び酵素的性質を第1表に示す。Two active fractions are obtained by this gel filtration, and the first eluted fraction is collected, concentrated, and then applied to a column (1. 2 × 50 cm), 0
The enzyme was eluted using a linear concentration gradient from M to 0.3 M in NaCl aqueous solution. A single active fraction eluted with an aqueous NaCl solution around 0.14 M was collected,
Concentrate and dialyze to obtain a purified sample of dextranase I (titer:
30.6 units/mg protein) was obtained. (3) On the other hand, among the two active fractions obtained by the gel filtration described above, the fraction eluted later was collected, concentrated, and then column filled with DEAE-Sepharose sufficiently equilibrated with the above buffer. (1.2 × 50 cm)
The enzyme was eluted using a linear concentration gradient from 0M to 0.3M NaCl aqueous solution. A single active fraction eluted with an aqueous NaCl solution around 0.16 M was collected,
A purified sample of dextranase II (titer: 59.2 units/mg protein) was obtained by concentration and dialysis. (4) Table 1 shows the physicochemical and enzymatic properties of dextranase I and II obtained as described above.
【0012】0012
【0013】[0013]
【実施例】以下、実施例により本発明を更に詳細に説明
するが、本発明はこれらにより何ら限定されるものでは
ない。EXAMPLES The present invention will be explained in more detail with reference to Examples below, but the present invention is not limited to these in any way.
【0014】[0014]
【実施例1】(1) ファルマシア製デキストランT
2000の15g を 5 mMのCa2+を含有する
20mM 酢酸緩衝液(pH6.0) の50 ml
に調製例で得たデキストラナーゼI 26 mgを1
00ml三角フラスコに入れ、35℃で24時間反応さ
せた。反応生成糖の経時変化を表す硝酸銀染色クロマト
グラムを第1図に示す。第1図において、Std は標
準糖質を、IG2 はイソマルトースを、IG3 はイ
ソマルトトリオースを、IG4 はイソマルトテトラオ
ースを、IG5 はイソマルトペンタオースを、IG6
はイソマルトヘキサオースを、 X1 は上記(I)
式のグルコ4糖を示す。(2) 反応終了後、生成糖
混液をカーボン−セライトカラムにかけた。先ず、10
%エタノールを用いてイソマルトトリオース(第2図の
フラクションチューブ番号115 付近)を溶出した後
、15%エタノールで溶出させると、イソマルトテトラ
オース(第2図のフラクションチューブ番号195 付
近)、式(I)のグルコ4糖(X1)(第2図のフラク
ションチューブ番号205 付近)、イソマルトペンタ
オース(第2図のフラクションチューブ番号220 付
近)が順次溶出された。[Example 1] (1) Dextran T manufactured by Pharmacia
15 g of 2000 in 50 ml of 20 mM acetate buffer (pH 6.0) containing 5 mM Ca2+
26 mg of dextranase I obtained in the preparation example was added to 1
The mixture was placed in a 00ml Erlenmeyer flask and reacted at 35°C for 24 hours. FIG. 1 shows a silver nitrate-stained chromatogram showing the change over time in the sugar produced by the reaction. In Figure 1, Std is standard carbohydrate, IG2 is isomaltose, IG3 is isomaltotriose, IG4 is isomaltotetraose, IG5 is isomaltopentaose, IG6 is
is isomaltohexaose, X1 is the above (I)
The formula glucotetrasaccharide is shown. (2) After the reaction was completed, the resulting sugar mixture was applied to a carbon-celite column. First, 10
After eluting isomaltotriose (near fraction tube number 115 in Figure 2) using % ethanol, elution with 15% ethanol yields isomaltotetraose (near fraction tube number 195 in Figure 2), formula Glucotetrasaccharide (X1) of (I) (near fraction tube number 205 in Figure 2) and isomaltopentaose (near fraction tube number 220 in Figure 2) were eluted in sequence.
【0015】結果を第2図に示す。式(I)のグルコ4
糖(X1)を含む画分は、まだ少量のイソマルトトリオ
ースとイソマルトテトラオースを含んでいるので、これ
らを除去するために基質特異性の高いArthroba
cter globiformisI42株起源のグル
コデキストラナーゼを35℃で24時間作用させてグル
コースにまで加水分解した。The results are shown in FIG. Gluco 4 of formula (I)
The fraction containing sugar (X1) still contains a small amount of isomaltotriose and isomaltotetraose, so in order to remove these, Arthroba with high substrate specificity was used.
Glucodextranase originating from S. cter globiformis I42 strain was allowed to act at 35° C. for 24 hours to hydrolyze it to glucose.
【0016】この反応によって式(I)のグルコ4糖だ
けがオリゴ糖として残存し、上記の少量の不純物質は全
てグルコース化される。この操作によって得られた物質
の分画をX−3とする。この分画X−3をペーパークロ
マトグラフィーで更に分画精製した。この分画をX−4
とする。[0016] Through this reaction, only the glucotetrasaccharide of formula (I) remains as an oligosaccharide, and all of the small amounts of impurities mentioned above are converted to glucose. The fraction of the substance obtained by this operation is designated as X-3. This fraction X-3 was further purified by paper chromatography. This fraction was
shall be.
【0017】この分画X−4に基質特異性の高くしかも
作用機作がよく知られている種々の酵素、即ち、A.g
lobiformis T6株起源のイソマルトデキス
トラナーゼ (第3図において「ID」と示す)(Ag
ric. Biol. Chem., Vol.52(
2), 495−501,1988; Agric.
Biol. Chem., Vol.52(3), 8
29−836, 1988) 、A.globifor
mis I42 株起源のグルコデキストラナーゼ (
第3図において「GD」と示す)(Agric. Bi
ol. Chem., Vol.52(9), 216
9−2176, 1988; Agric. Biol
. Chem., Vol.53(1), 223−2
28, 1989) 、Rhizopus niveu
s起源の結晶グルコアミラーゼ (第3図において「G
A」と示す)(BIO−CHEMICALS, PRO
CTS FOR LIFE SCIENCE, 1
989/1990 総合カタログ35頁 (生化学工業
株式会社出版), Glucoamylase(Rhi
zopus niveus)) を作用させた。第3図
においてP及びIPは、それぞれ標準糖質のパノース及
びイソパノースを示す。Fraction X-4 contains various enzymes with high substrate specificity and well-known mechanisms of action, including A. g
isomaltodextranase (indicated as “ID” in Fig. 3) originating from P. lobiformis T6 strain (Ag
ric. Biol. Chem. , Vol. 52 (
2), 495-501, 1988; Agric.
Biol. Chem. , Vol. 52(3), 8
29-836, 1988), A. globifor
Glucodextranase originating from mis I42 strain (
Indicated as “GD” in Fig. 3) (Agric. Bi
ol. Chem. , Vol. 52(9), 216
9-2176, 1988; Agric. Biol
.. Chem. , Vol. 53(1), 223-2
28, 1989), Rhizopus niveu
Crystalline glucoamylase originating from s (in Figure 3, “G
A) (BIO-CHEMICALS, PRO
CTS FOR LIFE SCIENCE, 1
989/1990 General Catalog 35 pages (Seikagaku Kogyo Co., Ltd. Publishing), Glucoamylase (Rhi
zopus niveus)). In FIG. 3, P and IP represent standard carbohydrates panose and isopanose, respectively.
【0018】これらの酵素反応サンプルをクロマトグラ
フィーにかけ反応生成糖を調べた。結果を第3図に示す
。グルコデキストラナーゼ及びグルコアミラーゼの両者
は式(I)のグルコ4糖X1 を全く加水分解できない
のに対し、イソマルトデキストラナーゼは X1 を加
水分解して、グルコースと3糖と思われる構造未知糖を
生成した。この結果、 X1 の非還元性末端はα−1
,6−、α−1,4−グルコシド結合以外の結合であり
、またX1 がグルコ4糖であるならば、非還元性末端
側から2番目の結合はα−1,6−グルコシド結合であ
ることが推測された。These enzyme reaction samples were subjected to chromatography to examine the sugars produced by the reaction. The results are shown in Figure 3. Both glucodextranase and glucoamylase cannot hydrolyze the glucotetrasaccharide produced sugar. As a result, the non-reducing end of X1 is α-1
, 6-, α-1,4-glucosidic bond, and if X1 is a glucotetrasaccharide, the second bond from the non-reducing end is an α-1,6-glucosidic bond. It was speculated that.
【0019】また、式(I)のグルコ4糖 X1 の1
3C−NMR スペクトル (重水中、室温) を第4
図に示す。酵素反応結果による糖結合方法と位置、及び
13C−NMR の解析結果から、本発明の上記(I)
式のグルコ4糖は、式(I)で示される3−O−α−D
−グルコシル−D−イソマルトトリオースであると同定
した。[0019] Furthermore, 1 of the glucotetrasaccharide X1 of formula (I)
3C-NMR spectrum (dew water, room temperature)
As shown in the figure. From the sugar binding method and position based on the enzyme reaction results and the 13C-NMR analysis results, the above (I) of the present invention
The glucotetrasaccharide of the formula is 3-O-α-D of the formula (I)
-glucosyl-D-isomaltotriose.
【0020】[0020]
【実施例2】ファルマシア製のデキストランT2000
の15 gを5 mMのCa2+を含有する20 mM
酢酸緩衝液(pH 6.0) の50 ml に調製
例で得たデキストラナーゼIIの30 mg を100
ml三角フラスコ中に入れ、35℃で24時間反応さ
せた。反応生成糖の経時変化を表す硝酸銀染色クロマト
グラムを第1図に示す。[Example 2] Dextran T2000 manufactured by Pharmacia
15 g of 20 mM containing 5 mM Ca2+
Add 30 mg of dextranase II obtained in the preparation example to 50 ml of acetate buffer (pH 6.0).
The mixture was placed in a ml Erlenmeyer flask and reacted at 35°C for 24 hours. FIG. 1 shows a silver nitrate-stained chromatogram showing the change over time in the sugar produced by the reaction.
【0021】以下、実施例1と同様に処理して式(I)
で示されるグルコ4糖を得た。[0021] Hereinafter, the same process as in Example 1 was carried out to obtain the formula (I).
A glucotetrasaccharide represented by was obtained.
【0022】[0022]
【実施例3】名糖産業製のデキストラン70の15 g
を5 mMのCa2+を含有する20 mM 酢酸緩衝
液(pH6.0)に、調製例で得たデキストラナーゼI
の25 mg を100 ml三角フラスコの中に加え
、35℃で24時間反応させた。以下実施例1と同様に
処理して式(I)で示されるグルコ4糖を得た。[Example 3] 15 g of dextran 70 manufactured by Meito Sangyo
Dextranase I obtained in the preparation example was added to 20 mM acetate buffer (pH 6.0) containing 5 mM Ca2+.
25 mg of was added to a 100 ml Erlenmeyer flask and reacted at 35°C for 24 hours. Thereafter, the same procedure as in Example 1 was carried out to obtain the glucotetrasaccharide represented by formula (I).
【0023】[0023]
【実施例4】名糖産業製のデキストラン70の15g
を5 mMのCa2+を含有する20 mM 酢酸緩衝
液(pH6.0)に、調製例で得たデキストラナーゼI
Iの35 mg を100 ml三角フラスコの中に加
え、35℃で24時間反応させた。以下実施例1と同様
に処理して式(I)で示されるグルコ4糖を得た。[Example 4] 15 g of dextran 70 manufactured by Meito Sangyo
Dextranase I obtained in the preparation example was added to 20 mM acetate buffer (pH 6.0) containing 5 mM Ca2+.
35 mg of I was added to a 100 ml Erlenmeyer flask and reacted at 35°C for 24 hours. Thereafter, the same procedure as in Example 1 was carried out to obtain the glucotetrasaccharide represented by formula (I).
【0024】[0024]
【発明の効果】本発明によれば、保湿剤として有用なグ
ルコ4糖である3−O−α−D−グルコシル−D−イソ
マルトトリオースを効率よく製造することができる。According to the present invention, 3-O-α-D-glucosyl-D-isomaltotriose, which is a glucotetrasaccharide useful as a humectant, can be efficiently produced.
【図1】反応生成糖の経時変化を表す硝酸銀染色クロマ
トグラムを示す図である。FIG. 1 is a diagram showing a silver nitrate-stained chromatogram showing changes over time in reaction-produced sugars.
【図2】カーボン−セライトカラムクロマトグラフィー
の溶出パターンを示す図である。FIG. 2 is a diagram showing the elution pattern of carbon-celite column chromatography.
【図3】本発明のグルコ4糖を種々の精製酵素で処理し
た試料のクロマトグラフィーの結果を示す図である。FIG. 3 is a diagram showing the results of chromatography of samples obtained by treating the glucotetrasaccharide of the present invention with various purified enzymes.
【図4】式(I)で示されるグルコ4糖の13C−NM
R スペクトルを示す図である。FIG. 4: 13C-NM of glucotetrasaccharide represented by formula (I)
It is a figure showing an R spectrum.
Claims (1)
ロビフォルミス(Arthro−bacter glo
biformis) 由来のデキストラナーゼI又はデ
キストラナーゼIIを作用させて次式(I)のグルコ4
糖を生成させることを特徴とするグルコ4糖の製造法。Claim 1: Dextran containing Arthro-bacter globiformis (Arthro-bacter globiformis)
gluco-4 of the following formula (I) by acting with dextranase I or dextranase II derived from
A method for producing glucotetrasaccharide, which is characterized by producing sugar.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2406104A JPH04222594A (en) | 1990-12-25 | 1990-12-25 | Production of glucotetrasaccharide |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2406104A JPH04222594A (en) | 1990-12-25 | 1990-12-25 | Production of glucotetrasaccharide |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH04222594A true JPH04222594A (en) | 1992-08-12 |
Family
ID=18515729
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2406104A Pending JPH04222594A (en) | 1990-12-25 | 1990-12-25 | Production of glucotetrasaccharide |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH04222594A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2050454A4 (en) * | 2006-08-10 | 2009-09-23 | House Wellness Foods Corp | Moisturizing agent |
-
1990
- 1990-12-25 JP JP2406104A patent/JPH04222594A/en active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2050454A4 (en) * | 2006-08-10 | 2009-09-23 | House Wellness Foods Corp | Moisturizing agent |
US8231882B2 (en) | 2006-08-10 | 2012-07-31 | House Wellness Foods Corporation | Moisturizer |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Walker et al. | The mechanism of carbohydrase action. 8. Structures of the muscle-phosphorylase limit dextrins of glycogen and amylopectin | |
Boyer et al. | Extracellular alkaline amylase from a Bacillus species | |
EP0096547B1 (en) | Process for preparing uridine diphosphate-n-acetylgalactosamine | |
US5089401A (en) | Method for the preparation of fructose-containing oligosaccharide | |
JPS61162183A (en) | Production of pullulanase-like enzyme | |
US4855232A (en) | Method for production of glucose by use of transglucosidase | |
JPH04222594A (en) | Production of glucotetrasaccharide | |
JPH10271992A (en) | Purified alpha-amylase stable to acid and obtained from fungi | |
JPH04200386A (en) | Beta-fructofuranosidase and production thereof | |
JP2992830B2 (en) | New β-glucuronidase | |
JP2767408B2 (en) | Manufacturing method of phosphate sugar | |
Maruo et al. | Enzymatic synthesis of high purity maltotetraose using moranoline (1-deoxynojirimycin) | |
JP3124356B2 (en) | Dextran production method | |
Yamamoto et al. | Arabinogalactanase of Bacillus subtilis var. amylosacchariticus | |
US3423288A (en) | Process for preparing gentiobiose | |
JPH0759584A (en) | Production of disaccharide and new disaccharide | |
JP3482454B2 (en) | Method for producing high-purity xyloglucan oligoheptasaccharide | |
JPS62146598A (en) | Production of n-acetylchitooligosaccharide by enzyme | |
JP2868835B2 (en) | Isomaltooligosaccharide-containing syrup and method for producing isomaltooligosaccharide | |
JP3045509B2 (en) | Method for producing mannose-containing oligosaccharides | |
Murooka et al. | Affinity chromatography of Klebsiella arylsulfatase on tyrosyl-hexamethylenediamino-β-1, 3-glucan and immunoadsorbent | |
KR960003644B1 (en) | Preparation process of isomalto-oligosaccharide | |
JPH01174383A (en) | Production of n-acetylchitooligosaccharide by enzyme | |
JPS60186296A (en) | Saccharification of starch | |
JPH062071B2 (en) | Saccharide manufacturing method |